| Pharmaceutical Information |
| Drug Name |
Zanamivir |
| Drug ID |
BADD_D02380 |
| Description |
A guanido-neuraminic acid that is used to inhibit neuraminidase. |
| Indications and Usage |
For the prevention and treatment of influenza A and B. |
| Marketing Status |
approved; investigational |
| ATC Code |
J05AH01 |
| DrugBank ID |
DB00558
|
| KEGG ID |
D00902
|
| MeSH ID |
D053243
|
| PubChem ID |
60855
|
| TTD Drug ID |
D00NPP
|
| NDC Product Code |
0173-0681; 63379-028 |
| UNII |
L6O3XI777I
|
| Synonyms |
Zanamivir | 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid | 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid | 5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid | 4-Guanidino-Neu5Ac2en | 4 Guanidino Neu5Ac2en | 2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid | 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid | 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid | Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic | Relenza | GG 167 | GG167 | GG-167 |
|
| Chemical Information |
| Molecular Formula |
C12H20N4O7 |
| CAS Registry Number |
139110-80-8 |
| SMILES |
CC(=O)NC1C(C=C(OC1C(C(CO)O)O)C(=O)O)N=C(N)N |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
|
|
|
